Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 16:11, 2 December 2020
   
Page name:

1 December 2020

 m   16:48  Acute myeloid leukemia‎ (diff | hist) . . (+885). . Jwarner (talk | contribs) (Decitabine & Venetoclax {{#subobject:30c499|Regimen=1}})

29 November 2020

 m   13:59  Non-small cell lung cancer‎ (diff | hist) . . (+4,939). . Jwarner (talk | contribs) (Investigational agents)
 m   13:58  Non-small cell lung cancer, EGFR-mutated‎ (diff | hist) . . (+14,520). . Jwarner (talk | contribs) (References)
 m   13:57  Non-small cell lung cancer, ALK-positive‎ (diff | hist) . . (+6,104). . Jwarner (talk | contribs) (References)
 m   08:41  Multiple myeloma, induction‎ (diff | hist) . . (+1,802). . Jwarner (talk | contribs) (First-line therapy (including transplant ineligible), randomized data)

28 November 2020

 m   13:30  Neuroblastoma‎ (diff | hist) . . (+12). . Jwarner (talk | contribs) (Naxitamab {{#subobject:ac2e27|Regimen=1}})

27 November 2020

     13:17  Eligibility criteria‎‎ (4 changes | history) . . (+171). . [Warner-admin‎ (4×)]
      13:17 (cur | prev) . . (+22). . Warner-admin (talk | contribs) (Screening for trials)
      09:38 (cur | prev) . . (+75). . Warner-admin (talk | contribs) (Screening for trials)
      09:30 (cur | prev) . . (+38). . Warner-admin (talk | contribs) (Screening for trials)
      09:26 (cur | prev) . . (+36). . Warner-admin (talk | contribs) (Screening for trials)

26 November 2020

     22:30  Eligibility criteria‎‎ (3 changes | history) . . (+523). . [Warner-admin‎ (3×)]
      22:30 (cur | prev) . . (+46). . Warner-admin (talk | contribs) (Screening for trials)
      22:15 (cur | prev) . . (+12). . Warner-admin (talk | contribs) (Screening for trials)
      22:07 (cur | prev) . . (+465). . Warner-admin (talk | contribs)

25 November 2020

     19:49  Neuroblastoma‎‎ (2 changes | history) . . (+1,492). . [PeterYang‎ (2×)]
 m    19:49 (cur | prev) . . (0). . PeterYang (talk | contribs) (Naxitamab {{#subobject:f725b0|Regimen=1}}: regimen/variant tag)
      19:48 (cur | prev) . . (+1,492). . PeterYang (talk | contribs) (Relapsed or refractory: added Naxitamab)
 m   19:18  Drug index‎ (diff | hist) . . (+61). . PeterYang (talk | contribs) (N)